iRhythm vs Orthofix Medical
Orthofix Medical reported revenue of $822 million in fiscal 2025, about the same as iRhythm's $747 million in fiscal 2025. iRhythm's revenue grew 26.2% in its latest year, and Orthofix Medical's grew 2.9%. iRhythm had an operating margin of -7.7%, against -9.9% at Orthofix Medical. Free cash flow was $35 million at iRhythm and −$1 million at Orthofix Medical.
Side by side
| iRhythm | Orthofix Medical | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $747M | $822M |
| Revenue growth | 26.2% | 2.9% |
| Revenue growth a year, last 5 years | 23.0% | 15.1% |
| Gross margin | 70.6% | 68.8% |
| Operating margin | −7.7% | −9.9% |
| Net margin | −6.0% | −11.2% |
| Free cash flow | $35M | −$1M |
| Free cash flow margin | 4.6% | −0.2% |
| Return on capital | −12.4% | −11.3% |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 2.6% | 3.9% |
| Last close | $94.24 | $6.34 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | bought $820,598, sold $22.7 million | bought $4.1 million, sold $6.6 million |
| Piotroski F-score | 5 of 9 | 5 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
iRhythmOrthofix Medical
Operating margin
Percent of revenue
iRhythmOrthofix Medical
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
iRhythmOrthofix Medical
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the iRhythm and Orthofix Medical pages.